
September 22, 2010 — The US Food and Drug Administration (FDA) today announced approval of fingolimod (Gilenya, Novartis), the first of the long-anticipated oral treatments for multiple sclerosis (MS). Fingolimod is approved to reduce relapses and delay disability progression in patients with relapsing forms of MS, an FDA release notes.
快樂小藥師 發表在 痞客邦 留言(0) 人氣(572)

Expert Interview With Jack E. Ansell, MD
Linda Brookes, MSc
快樂小藥師 發表在 痞客邦 留言(0) 人氣(533)
By
Fran Lowry
Medscape Medical News
快樂小藥師 發表在 痞客邦 留言(0) 人氣(358)
Acetaminophen Use in Adolescents May Double
Risk for Asthma
News
Author: Laurie Barclay, MD
CME Author: Penny Murata, MD
快樂小藥師 發表在 痞客邦 留言(0) 人氣(433)

Roxanne Nelson
Authors and Disclosures
Posted: 06/21/2010
快樂小藥師 發表在 痞客邦 留言(0) 人氣(198)

今天來練習一下抗潰瘍藥物吧
先來個前測:
1.Which of these proton-pump inhibitors are not affected by food intake?
A.Esomeprazole and omeprazole
快樂小藥師 發表在 痞客邦 留言(0) 人氣(3,752)